Development of 2-(5,6,7-Trifluoro-1 H-Indol-3-yl)-quinoline-5-carboxamide as a Potent, Selective, and Orally Available Inhibitor of Human Androgen Receptor Targeting Its Binding Function-3 for the Treatment of Castration-Resistant Prostate Cancer
Eric Leblanc, Fuqiang Ban, Ayse Derya Cavga, Sam Lawn, Chia Chi Flora Huang, Sankar Mohan, Matthew E.K. Chang, Mark R. Flory, Fariba Ghaidi, Shreyas Lingadahalli, Gang Chen, Ivan Pak Lok Yu, Hélène Morin, Nada Lallous, Martin E. Gleave, Hisham Mohammed, Robert N. Young, Paul S. Rennie, Nathan A. Lack, Artem Cherkasov
Dive into the research topics of 'Development of 2-(5,6,7-Trifluoro-1 H-Indol-3-yl)-quinoline-5-carboxamide as a Potent, Selective, and Orally Available Inhibitor of Human Androgen Receptor Targeting Its Binding Function-3 for the Treatment of Castration-Resistant Prostate Cancer'. Together they form a unique fingerprint.